Please login to the form below

Not currently logged in
Email:
Password:

CytomX makes senior changes following Pfizer deal

Krishna Polu joins as chief medical officer and Debanjan Ray promoted to VP, business development

CytomX Therapeutics has boosted both its senior science and business teams following a major antibody deal with Pfizer.

Dr Krishna Polu leaves troubled US biotech Affymax to join CytomX as chief medical officer, while former senior director, head of business development, Debanjan Ray is promoted to VP, busienss development and alliance management.

Both positions will be crucial to supporting the San Francisco-based biotech's growth following CytomX's $635m deal agreed with Pfizer last month to develop a series of antibody-drug conjugates (ADCs) for cancer. 

During his time at Affymax, Dr Polu headed several areas, including clinical sciences, clinical operations and drug safety/pharmacovigilance.

He was also one of the key figures behind the development and approval of Affymax' first drug Omontys (peginasetide), although this drug has since been pulled from market in the US after several people died as a result of severe hypersensitivity reactions.

Prior to this period at Affymax, Dr Polu was executive director, global development at Amgen, where he worked in the development of products in nephrology, diabetes and heart failure.

His new colleague Ray joined CytomX in 2011 and was instrumental in brokering the agreement with Pfizer.

His promotion to this newly-created role is a signal of intent from CytomX that it is keen on developing similar partnerships that utilise its probody technology.

“We are very pleased to promote Debanjan in parallel with adding Krishna to the CytomX team,” said Dr Sean McCarty, CEO of CytomX.

“This advancement highlights our continued focus on strategic business development and the formation of value-added alliances through which we can advance our pipeline of innovative probody therapeutics,” he added.

26th July 2013

From: Research, Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
emotive.

emotive. is an award-winning healthcare communications agency working with leading global and EMEA companies in life sciences including medical device...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics